SCHEMBL24390975

SCHEMBL24390975

COC(=O)c1cccc(C)c1-c1ccccc1-c1cccc(-c2ccccc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.52
FGFR2 P21802 2/20 0.52
FGFR4 P22455 2/20 0.52
FGFR3 P22607 2/20 0.52
MEN1 O00255 2/20 0.50
MAPT P10636 2/20 0.50
KMT2A Q03164 2/20 0.50
TSHR P16473 1/20 0.50
HTT P42858 1/20 0.50
MAPK10 P53779 1/20 0.50
PTK2B Q14289 1/20 0.50
NCOA1 Q15788 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
NCOA3 Q9Y6Q9 1/20 0.50
SLC6A3 Q01959 5/20 0.48
SLC6A4 P31645 3/20 0.48
SLC6A2 P23975 1/20 0.48
MYC P01106 1/20 0.48
ALDH1A1 P00352 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22256436 0.92 FGFR1 (0.57) FGFR1FGFR2FGFR4FGFR3MEN1
SCHEMBL22256427 0.90 FGFR1 (0.56) FGFR1FGFR2FGFR4FGFR3MEN1
SCHEMBL22256471 0.84 SLC6A3 (0.57) FGFR1FGFR2FGFR4FGFR3MEN1
SCHEMBL24390974 0.83 TSHR (0.57) FGFR1FGFR2FGFR4FGFR3MEN1
SCHEMBL17372744 0.82 MAPT (0.60) FGFR1FGFR2FGFR4FGFR3MEN1
SCHEMBL4957139 0.82 FABP4 (0.56) FGFR1FGFR2FGFR4FGFR3MEN1
SCHEMBL22256428 0.82 MAPT (0.54) FGFR1FGFR2FGFR4FGFR3MEN1
SCHEMBL30285287 0.79 SLC6A3 (0.71) MEN1MAPTKMT2ATSHRHTT
SCHEMBL22256467 0.79 EGFR (0.54) MEN1MAPTKMT2AHTTSMN1; SMN2
SCHEMBL22256466 0.78 HDAC7 (0.49) MEN1MAPTKMT2AHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220140245-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220140245-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES PIEZO1, NES, ILK FGFR1 1695/4885FGFR2 1889/4885FGFR4 2547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.